CAS 201341-05-1
:Tenofovir disoproxil
Description:
Tenofovir disoproxil is an antiretroviral medication primarily used in the treatment and prevention of HIV/AIDS and chronic hepatitis B infection. It is a prodrug of tenofovir, which means it is metabolized in the body to its active form. The substance is characterized by its ability to inhibit the reverse transcriptase enzyme, thereby preventing viral replication. Chemically, it is classified as a nucleotide analog and is known for its high oral bioavailability. Tenofovir disoproxil is typically administered in the form of a fumarate salt, enhancing its stability and absorption. The compound is soluble in water and exhibits a relatively long half-life, allowing for once-daily dosing. Its safety profile is generally favorable, although it may be associated with renal toxicity and bone mineral density loss in some patients. As a key component of combination therapy regimens, tenofovir disoproxil has played a significant role in reducing the incidence of HIV transmission and improving the quality of life for individuals living with HIV.
Formula:C19H30N5O10P
InChI:InChI=1S/C19H30N5O10P/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22)/t14-/m1/s1
InChI key:InChIKey=JFVZFKDSXNQEJW-CQSZACIVSA-N
SMILES:C([C@H](OCP(OCOC(OC(C)C)=O)(OCOC(OC(C)C)=O)=O)C)N1C=2C(N=C1)=C(N)N=CN2
Synonyms:- 2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, 1,9-bis(1-methylethyl) ester, 5-oxide
- 2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, bis(1-methylethyl) ester, 5-oxide
- 2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, bis(1-methylethyl) ester, 5-oxide, (R)-
- 9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine
- Bis-POC-PMPA
- Gs 4331
- TD
- bis({[(1-methylethoxy)carbonyl]oxy}methyl) {[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl}phosphonate
- Tenofovir disoproxil
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, 1,9-bis(1-methylethyl) ester, 5-oxide
CAS:Formula:C19H30N5O10PPurity:98%Color and Shape:SolidMolecular weight:519.4428Tenofovir Disoproxil
CAS:<p>Tenofovir Disoproxil (GS 4331) is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B.</p>Formula:C19H30N5O10PPurity:99.17%Color and Shape:SolidMolecular weight:519.44Tenofovir disoproxil
CAS:<p>Anti-viral; reverse transcriptase inhibitor</p>Formula:C19H30N5O10PPurity:Min. 95%Color and Shape:White PowderMolecular weight:519.44 g/mol(R)-(((((1-(6-Amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(oxy))bis(methylene) diisopropyl dicarbonate
CAS:Formula:C19H30N5O10PPurity:98%+;RGColor and Shape:SolidMolecular weight:519.448Tenofovir Disoproxil
CAS:Controlled Product<p>Applications Tenofovir Disoproxil is a therapeutic option for nucleos(t)ide analog (NA)-experienced chronic hepatitis B (CHB) patients infected with hepatitis B virus (HBV). Also, it is an intermediate used in the synthesis of Tenofovir Disoproxil Dimer (T018515), which is a Tenofovir Disoproxil impurity.<br>References Huang, M., et al.: Clin. Drug Investig., 36, 471-478 (2016); Cheng, G., et al.: Chem. Res. Toxicol., 16, 145 (2003)<br></p>Formula:C19H30N5O10PColor and Shape:NeatMolecular weight:519.443





